Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: RANEXA

« Back to Dashboard

Summary for Tradename: RANEXA

Patents:10
Applicants:1
NDAs:1
Suppliers: see list3

Pharmacology for Tradename: RANEXA

Drug ClassAnti-anginal

Clinical Trials for: RANEXA

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Status: Completed Condition: End-stage Renal Disease; Cardiovascular Disease

A Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation (HARMONY)
Status: Completed Condition: Atrial Fibrillation

Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Status: Completed Condition: Myocardial Perfusion Imaging; Myocardial Ischemia

Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion
Status: Completed Condition: Persistent Atrial Fibrillation

Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
Status: Completed Condition: Type 2 Diabetes Mellitus

Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
Status: Recruiting Condition: Diabetic Peripheral Neuropathic Pain

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Status: Recruiting Condition: Diarrhea Predominant Irritable Bowel Syndrome

Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
Status: Completed Condition: Type 2 Diabetes Mellitus

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy
Status: Completed Condition: Diabetes Mellitus, Type 2

Study to Reduce Symptoms of Premature Beats With Ranolazine
Status: Not yet recruiting Condition: Premature Ventricular Beats

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gilead
RANEXA
ranolazine
TABLET, EXTENDED RELEASE;ORAL021526Jan 27, 2006RXNo6,503,911<disabled>Y<disabled>
Gilead
RANEXA
ranolazine
TABLET, EXTENDED RELEASE;ORAL021526Jan 27, 2006RXNo6,864,258<disabled><disabled>
Gilead
RANEXA
ranolazine
TABLET, EXTENDED RELEASE;ORAL021526Feb 12, 2007RXYes6,303,607<disabled><disabled>
Gilead
RANEXA
ranolazine
TABLET, EXTENDED RELEASE;ORAL021526Feb 12, 2007RXYes6,369,062<disabled>YY<disabled>
Gilead
RANEXA
ranolazine
TABLET, EXTENDED RELEASE;ORAL021526Jan 27, 2006RXNo6,617,328<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc